Lorraine Witten had been on the board since 2017 and chair since 2022, but her departure forms part of a ‘board refresh’.
Analysts are positive about equities in 2025, but their diverse views suggest investors need to do their homework rather than just follow the index.
WATCH: How NZ King Salmon is preparing for growth while navigating existing headwinds and government goals.
According to one analyst, 2025 just can’t be as bad as 2024.
Comvita has attributed a downgraded loss to aggressive competition and the associated gross margin pressure.
The wider remuneration report also received a ‘first strike’ at the bank’s annual meeting.
‘The NZX code is a best practice recommendation, and it’s not mandatory, the board is satisfied,’ chair tells shareholders.
Crescent Capital Partners is offering just 8 cents per share for the company. Metro’s board turned down an offer for 18 cps in 2023.
Metro Performance Glass says the offer from Crescent Capital Partners is unlikely to be in the interests of shareholders.
The NZX-listed wellness brand has left the door ajar for another capital raise.